Orthotopic liver transplant recipient with Enteric-coated Mycophenolate Sodium induced small bowel ulcers: two case reports

Enteric-coated Mycophenolate Sodium(EC-MPS), one preparation of Mycophenolic acid(MPA), is an immunosuppressive drug commonly used after liver transplantation to prevent allograft rejection. EC-MPS induced small bowel ulcers are very rare and have not been reported in liver transplant recipients. Herein, we report two patients considered with small bowel ulcers induced by EC-MPS (a diagnosis of exclusion). Case 1: A 56-year-old male complained of melena 40 days after orthotopic liver transplantation. Emergency esophagogastroduodenoscopy and colonoscopy did not find bleeding sites. His hemoglobin level was 47 g/L. Further small bowel endoscopy revealed an ulcer. EC-MPS was discontinued, and the small bowel capsule endoscopy showed the small bowel ulcer was completely healed 10 days later. The patient recovered well, and there was no melena during a follow-up period of 7 months. Case 2: Another 56-year-old male complained of melena 21 days after orthotopic liver transplantation. Emergency esophagogastroduodenoscopy and colonoscopy revealed mild esophageal varices and did not find active bleeding sources. His hemoglobin level was 68 g/L. Further small bowel endoscopy showed multiple large, irregular ulcers. Based on the clinical experience of managing case 1, EC-MPS was discontinued and substituted with mycophenolate mofetil (MMF). Then gastrointestinal hemorrhage was resolved, and enteral nutrition was gradually restored. Unfortunately, the patient ultimately died of a life-threatening infection. Although usually regarded as a diagnosis of exclusion, liver transplantation recipients presented with small bowel ulcer need to be vigilant about the possibility of side effects of immunosuppressive agents, especially EC-MPS. Timely identification and adjustment of medication may improve the clinical outcome of patients. Heightened clinical awareness of this pharmacological association is strongly advocated.

Authors

Institutions

Publication Details

Journal
BMC Surgery
Published
2025-11-28
DOI
https://doi.org/10.1186/s12893-025-03354-1
Citations
1
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
1.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Orthotopic liver transplant recipient with Enteric-coated Mycophenolate Sodium induced small bowel ulcers: two case reports

Shouping Wang, Tao� Lv, Jiaying Yang, Wenbo Niu
1 citations
BMC Surgery
Renal Transplantation Outcomes and Treatments
1.99
article

Orthotopic liver transplant recipient with Enteric-coated Mycophenolate Sodium induced small bowel ulcers: two case reports

Shouping Wang, Tao� Lv, Jiaying Yang, Wenbo Niu
article en
1 citations

Abstract

Enteric-coated Mycophenolate Sodium(EC-MPS), one preparation of Mycophenolic acid(MPA), is an immunosuppressive drug commonly used after liver transplantation to prevent allograft rejection. EC-MPS induced small bowel ulcers are very rare and have not been reported in liver transplant recipients. Herein, we report two patients considered with small bowel ulcers induced by EC-MPS (a diagnosis of exclusion). Case 1: A 56-year-old male complained of melena 40 days after orthotopic liver transplantation. Emergency esophagogastroduodenoscopy and colonoscopy did not find bleeding sites. His hemoglobin level was 47 g/L. Further small bowel endoscopy revealed an ulcer. EC-MPS was discontinued, and the small bowel capsule endoscopy showed the small bowel ulcer was completely healed 10 days later. The patient recovered well, and there was no melena during a follow-up period of 7 months. Case 2: Another 56-year-old male complained of melena 21 days after orthotopic liver transplantation. Emergency esophagogastroduodenoscopy and colonoscopy revealed mild esophageal varices and did not find active bleeding sources. His hemoglobin level was 68 g/L. Further small bowel endoscopy showed multiple large, irregular ulcers. Based on the clinical experience of managing case 1, EC-MPS was discontinued and substituted with mycophenolate mofetil (MMF). Then gastrointestinal hemorrhage was resolved, and enteral nutrition was gradually restored. Unfortunately, the patient ultimately died of a life-threatening infection. Although usually regarded as a diagnosis of exclusion, liver transplantation recipients presented with small bowel ulcer need to be vigilant about the possibility of side effects of immunosuppressive agents, especially EC-MPS. Timely identification and adjustment of medication may improve the clinical outcome of patients. Heightened clinical awareness of this pharmacological association is strongly advocated.

BMC SurgeryVol. 25(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), West China Medical Center of Sichuan University (CN), West China Hospital of Sichuan University (CN)
Openalex Percentile: Top 10%
Renal Transplantation Outcomes and Treatments
1.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.